Ling Rui Pharmaceutical (600285) announcement, the company intends to Xinyang Commercial Bank Co., Ltd. to increase the capital of 10 million shares, increase the share price of RMB 1.60 yuan/share, the total amount of capital increase of RMB 16 million yuan. After the increase in capital, the company will account for the current total of Xinyang firm 15.58% of Equity. The company released semi-annual report shows that the company to achieve operating profit of 22.157 million yuan, down 1.23% year-on-year, to achieve net profit of 16.53 million yuan, down 19.2% year-on-year. The basic earnings per share is 0.082 yuan. The first half of the company's pharmaceutical industry operating profit rate of 58.68%, the year-on-year decrease of 4.34%. The report said that the rubber paste gross profit margin year-on-year decline is due to the rise in raw material costs, the tablet gross profit margin year-on-year rise is due to technological improvements; Other gross profit margin is mainly due to the improvement of particle technology.
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.
